(Q49047468)

English

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.

scientific article published on 27 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. (English)

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

1 reference

based on heuristic

inferred from title

author name string

Kenneth R Chapman

1

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Jonathan G W Burdon

2

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Eeva Piitulainen

3

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Robert A Sandhaus

4

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Niels Seersholm

5

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

James M Stocks

6

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Berend C Stoel

7

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Liping Huang

8

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Zhenling Yao

9

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Jonathan M Edelman

10

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

Noel G McElvaney

11

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

RAPID Trial Study Group

12

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

language of work or name

0 references

publication date

27 May 2015

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

386

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

360-368

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

9991

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of mortality in alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Volume correction in computed tomography densitometry for follow-up studies on pulmonary emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1ra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic and biochemical markers of obstructive lung disease in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in forced expiratory volume in 1 second over time in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960860-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(15)60860-1

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/26026936

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49047468&oldid=1770216155"